Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Cash from Investing Activities (2024 - 2025)

Historic Cash from Investing Activities for Kura Oncology (KURA) over the last 2 years, with Q3 2025 value amounting to $94.0 million.

  • Kura Oncology's Cash from Investing Activities rose 10635.99% to $94.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$43.5 million, marking a year-over-year change of. This contributed to the annual value of -$101.6 million for FY2024, which is 75301.79% down from last year.
  • Latest data reveals that Kura Oncology reported Cash from Investing Activities of $94.0 million as of Q3 2025, which was up 10635.99% from $58.9 million recorded in Q2 2025.
  • Kura Oncology's Cash from Investing Activities' 5-year high stood at $94.0 million during Q3 2025, with a 5-year trough of -$101.4 million in Q1 2025.